Skip to main content
Year archive

Medacta Group SA — 2024 filings

All 30 regulatory filings released by Medacta Group SA (MOVE) in 2024, sourced directly from the official regulator.

30 Filings
2024 Period
2024 filings (30)
Filing Released Lang
Medacta unveils the extended enhancements to its Hip Revision Platform
Regulatory Filings
2024-10-21 English
Medacta Hosts Inaugural Capital Markets Day, Showcasing Responsible Innovation and Effective Growth Strategy
Earnings Release FY 2024
2024-09-30 English
Medacta Hosts Inaugural Capital Markets Day, Showcasing Responsible Innovation and Effective Growth Strategy
Earnings Release 9M 2024
2024-09-30 English
Medacta Group SA reports revenue growth of 14.3% at constant currency and adjusted EBITDA margin 26.9%, or 28.1% at constant currency in 1H 2024.
Earnings Release H1 2024
2024-09-25 English
Medacta NextAR Rod Optimizer, a Disruptive Technology Redefining Rod Management in Spine Surgery, wins the 2024 Spine Technology Award from Orthopedics This Week
Regulatory Filings
2024-09-24 English
Medacta Introduces a Simplified Approach for the M-ARS ACL Technique at the AGA Congress 2024, Mimicking the Native Ligament Footprint with an Optimized Surgical Flow
Regulatory Filings
2024-09-12 English
Medacta Enters Partnership with THINK Surgical for Robotic Total Knee Arthroplasty Solution
M&A Activity
2024-08-29 English
Medacta Enters Partnership with THINK Surgical for Robotic Total Knee Arthroplasty Solution
M&A Activity
2024-08-29 English
Mighty Oak Medical and Medacta Announce Non-Exclusive Worldwide License of Patents for Patient-Specific Pedicle Screw Guides
Legal Proceedings Report
2024-08-28 English
Mighty Oak Medical and Medacta Announce Non-Exclusive Worldwide License of Patents for Patient-Specific Pedicle Screw Guides
Regulatory Filings
2024-08-28 English
Medacta Group SA: Medacta Group SA revenues grew 14.3% at constant currency in 1H 2024
Earnings Release H1 2024
2024-07-24 English
Medacta Group SA: Medacta Group SA revenues grew 14.3% at constant currency in 1H 2024
Earnings Release H1 2024
2024-07-24 English
Medacta 25th Anniversary World Tour continues with events in Australia and the United States focusing on Personalized and Sustainable Total Knee Arthroplasty
Regulatory Filings
2024-05-30 English
Medacta 25th Anniversary World Tour continues with events in Australia and the United States focusing on Personalized and Sustainable Total Knee Arthroplasty
Regulatory Filings
2024-05-30 English
Medacta announces the results of today's Annual General Meeting
AGM Information
2024-05-07 English
Medacta announces the results of today's Annual General Meeting
AGM Information
2024-05-07 English
Medacta announces the 10th M.O.R.E. International Symposium in Lugano, Switzerland, celebrating its 25th anniversary worldwide
Environmental & Social Information
2024-04-11 English
Medacta annuncia il 10th M.O.R.E. International Symposium a Lugano, in Svizzera, celebrando il suo 25º anniversario in tutto il mondo
Regulatory Filings
2024-04-11 Italian
Medacta announces the 10th M.O.R.E. International Symposium in Lugano, Switzerland, celebrating its 25th anniversary worldwide
Regulatory Filings
2024-04-11 English
Medacta publishes 2024 Annual General Meeting invitation
AGM Information
2024-04-09 English
Medacta publishes 2024 Annual General Meeting invitation
AGM Information
2024-04-09 English
Medacta Group SA: Medacta Group SA reports robust revenue growth of 19.5% at constant currency and adjusted EBITDA1 margin 26.3%, or 27.9% at constant currency in FY 2023
Earnings Release FY 2023
2024-03-13 English
Medacta Group SA: Medacta Group SA reports robust revenue growth of 19.5% at constant currency and adjusted EBITDA1 margin 26.3%, or 27.9% at constant currency in FY 2023
Earnings Release FY 2023
2024-03-13 English
Annual Report 2023
Annual Report FY 2023
2024-03-12 English
Medacta to Feature GMK SpheriKA and Innovative Personalized Solutions at AAOS 2024
Regulatory Filings
2024-02-12 English
Medacta to Feature GMK SpheriKA and Innovative Personalized Solutions at AAOS 2024
Report Publication Announcement
2024-02-12 English
Medacta Group SA: Medacta Group SA revenues up +19.5% at constant currency1 exceeding the milestone of 500Mln in FY 2023
Earnings Release FY 2023
2024-02-02 English
Medacta Group SA: Medacta Group SA revenues up +19.5% at constant currency1 exceeding the milestone of 500Mln € in FY 2023
Earnings Release FY 2023
2024-02-02 English
Medactas QUADRA-H hip stem achieves 13A* exemplary quality rating from the British Orthopaedic Data Evaluation Panel (ODEP)
Regulatory Filings
2024-01-08 English
Medacta’s QUADRA-H hip stem achieves 13A* exemplary quality rating from the British Orthopaedic Data Evaluation Panel (ODEP)
Regulatory Filings
2024-01-08 English